N -(2-aminoethyl) Acetamide Additive Enables Phase-Pure and Stable α-FAPbI3 for Efficient Self-Powered Photodetectors
© 2022 Wiley-VCH GmbH.
Veröffentlicht in: | Advanced materials (Deerfield Beach, Fla.). - 1998. - 34(2022), 51 vom: 17. Dez., Seite e2208325 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2022
|
Zugriff auf das übergeordnete Werk: | Advanced materials (Deerfield Beach, Fla.) |
Schlagworte: | Journal Article FAPbI3 additive perovskites phase transitions photodetectors |
Zusammenfassung: | © 2022 Wiley-VCH GmbH. Formamidinium-lead triiodide (FAPbI3 ) perovskite is considered as one of the most promising perovskite materials for high-performance photodetectors because of its narrow bandgap and superior thermal stability. Nevertheless, to realize efficient carrier transport and highly performing photodetectors, it imposes the requirement of fabricating α-FAPbI3 with pure phase, preferred crystal orientation, large grain size, and passivated interface, which still remains challenging. Here, a facile strategy based on additive engineering to obtain pure-phase FAPbI3 perovskite films by introducing N-(2-aminoethyl) acetamide into perovskite precursors is reported. The formation of chemical bond and hydrogen bond between N-(2-aminoethyl) acetamide and perovskite reduces the potential barrier in the phase-transition process from an intermediate yellow phase to a final black phase, passivates the defects of the film, and leads to a high-quality and phase-pure α-FAPbI3 perovskite. A self-powered photodetector based on the as-fabricated FAPbI3 film exhibits a maximum responsivity of 0.48 A W-1 at 700 nm with a peak external quantum efficiency of 95% at 440 nm. Moreover, the optimized device remains 83% of the initial performance after 576 h storage at ambient condition. This work provides a simple and feasible scheme for the preparation of high-quality phase-pure α-FAPbI3 perovskite and associated devices |
---|---|
Beschreibung: | Date Completed 23.12.2022 Date Revised 23.12.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
ISSN: | 1521-4095 |
DOI: | 10.1002/adma.202208325 |